ASYMCHEM LAB.(TIAN.)H YC1

Research ASYMCHEM LAB.(TIAN.)H YC1 (7K90) on Bullrun: valuation model: 15.0% overvalued, market cap EUR 3.68B, P/E 25.5, dividend yield 1.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker7K90
• ExchangeF
• CountryChina
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Valuation signal15.0% overvalued
• Market capEUR 3.68B
• P/E25.5
• Dividend yield1.6%
• Financial periodQ1 2026
• RevenueEUR 1.80B
• Net incomeEUR 304.32M
• Free cash flowEUR 179.11M
• Gross margin43.0%

Valuation Snapshot

Bullrun's latest valuation model marks ASYMCHEM LAB.(TIAN.)H YC1 as 15.0% overvalued; latest market cap is EUR 3.68B; P/E is 25.5; dividend yield is 1.6%.

About ASYMCHEM LAB.(TIAN.)H YC1

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business.

Frequently asked questions

Is ASYMCHEM LAB.(TIAN.)H YC1 overvalued or undervalued?

Bullrun's valuation model currently marks ASYMCHEM LAB.(TIAN.)H YC1 as 15.0% overvalued.

What is ASYMCHEM LAB.(TIAN.)H YC1's market cap?

ASYMCHEM LAB.(TIAN.)H YC1's market capitalization is EUR 3.68B.

What is ASYMCHEM LAB.(TIAN.)H YC1's P/E ratio?

ASYMCHEM LAB.(TIAN.)H YC1's price-to-earnings (P/E) ratio is 25.5.

Does ASYMCHEM LAB.(TIAN.)H YC1 pay a dividend?

ASYMCHEM LAB.(TIAN.)H YC1 has a dividend yield of 1.6%.

What does ASYMCHEM LAB.(TIAN.)H YC1 do?

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally.